EUVIMEDEUVIMED entdecken
Crossref

Targeted delivery of activatable 131I-radiopharmaceutical for sustained radiotherapy with improved pharmacokinetics

Ke Li, Qiqi Wang, Xiaoqing Gao, Hongjie Xi, Di Hua, Huijie Jiang, Ling Qiu, Jianguo Lin

Journal of Controlled Release · 2024

DOI: 10.1016/j.jconrel.2024.07.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024. Verfasst von Ke Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, Chi…. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Radiopharmaceuticals, Cysteine Endopeptidases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted radionuclide therapy (TRT) is an effective treatment for tumors. Self-condensation strategies can enhance the retention of radionuclides in tumors and enhance the anti-tumor effect. Considering legumain is overexpressed in multiple types of human cancers, a 131I-labeled radiopharmaceutical ([131I]MAAN) based on the self-condensation reaction between 2-cyanobenzothiazole (CBT) and cysteine (Cys) was developed by us recently for treating legumain-overexpressed tumors. However, liver enrichment limits its application. In this study, a new radiopharmaceutical [131I]IM(HE)3AAN was designed and synthesized by introducing a hydrophilic peptide sequence His-Glu-His-Glu-His-Glu ((HE)3) into [131I]MAAN to optimize the pharmacokinetics. Upon activation by legumain under a reducing environment, hydrophilic [131I]IM(HE)3AAN could react with its precursor to form heterologous dimer [131I]H-Dimer that is highly hydrophobic. Cerenkov imaging revealed that [131I]IM(HE)3AAN displayed superior tumor selectivity and longer tumor retention time as compared with [131I]MAAN, with a significant reduction in the liver uptake. After an 18-day treatment with [131I]IM(HE)3AAN, the tumor proliferation was obviously inhibited, while no obvious injury was observed in the normal organs. These findings suggest that [131I]IM(HE)3AAN could serve as a promising drug candidate for treating legumain-overexpressed tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Iodine RadioisotopesRadiopharmaceuticalsCysteine EndopeptidasesAnimalsHumansCell Line, TumorNeoplasmsMice, Inbred BALB CMice, NudeTissue DistributionMiceFemaleAsparaginyl Endopeptidase

Stichwörter der Autor:innen

Condensation reactionHistidine–glutamate tagLegumainTargeted radionuclide therapy

Substanzen

Iodine RadioisotopesRadiopharmaceuticalsCysteine EndopeptidasesAsparaginyl EndopeptidaseIodine-131

Autor:innen und Institutionen

  • NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, China.
  • Department of Radiology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.
  • NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, China. Electronic address: qiuling@jsinm.org.
  • NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, China. Electronic address: linjianguo@jsinm.org.

Zitieren

APA

Li, K., Wang, Q., Gao, X., Xi, H., Hua, D., Jiang, H., Qiu, L., & Lin, J. (2024). Targeted delivery of activatable 131I-radiopharmaceutical for sustained radiotherapy with improved pharmacokinetics. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2024.07.005

Vancouver

Li K, Wang Q, Gao X, Xi H, Hua D, Jiang H, et al. Targeted delivery of activatable 131I-radiopharmaceutical for sustained radiotherapy with improved pharmacokinetics. Journal of Controlled Release. 2024. doi:10.1016/j.jconrel.2024.07.005

BibTeX
@article{Li2024,
  author = {Li, Ke and Wang, Qiqi and Gao, Xiaoqing and Xi, Hongjie and Hua, Di and Jiang, Huijie and Qiu, Ling and Lin, Jianguo},
  title = {Targeted delivery of activatable 131I-radiopharmaceutical for sustained radiotherapy with improved pharmacokinetics},
  journal = {Journal of Controlled Release},
  year = {2024},
  doi = {10.1016/j.jconrel.2024.07.005}
}
Kostenlos starten →